NCT04920981View on ClinicalTrials.gov

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

CompletedOBSERVATIONAL
Enrollment

518

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

November 24, 2021

Study Completion Date

September 1, 2024

Conditions
Small Cell Lung Cancer
Interventions
OTHER

atezolizumab

observational

Trial Locations (2)

Unknown

Chalon-sur-Saône - CH, Chalon-sur-Saône

Paris - Institut Curie, Paris

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

GFPC

UNKNOWN

lead

Intergroupe Francophone de Cancerologie Thoracique

OTHER

NCT04920981 - Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC | Biotech Hunter | Biotech Hunter